Similar oncogenic effects have been reported in other malignancies characterized by elevated GPC3 expression, including ovarian clear cell carcinoma [86], cervical cancer [87], lung squamous carcinoma [88] and gastric cancer cells [89]. The gene discussed is GPC3; the disease is ovarian clear cell cancer.